Skip to main content
  • Register
  • Login
Sort By
Narwhal Menu
  • Search
  • Menu
  • About Sandoz
    • About Sandoz
    • Contact Us
  • Therapy Areas
    • Therapy Areas
    • Anti-Infectives
      • Respiratory Tract Infections
      • Skin Infections
      • Urinary Tract Infections
    • CNS
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Bipolar Disorder
      • Insomnia
      • Migraine
      • Schizophrenia
    • Cardiovascular
      • Dyslipidemia
      • Hypertension
      • Thrombosis
    • Endocrinology
      • Diabetes
      • Growth Hormone Deficiency (GHD)
    • Gastrointestinal Tract
      • Gastro-oesophageal Reflux Disease (GORD)
      • Heartburn
    • Immunology
      • Rheumatology
      • Dermatology
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Ovarian Cancer
      • Prostate Cancer
      • Supportive Care
    • Pain
      • Acute Pain
      • Chronic Pain
    • Respiratory
      • Wet Cough and Sinus Congestion
    • Transplant
      • Heart Transplant
      • Kidney Transplant
      • Liver Transplant
    • Travel Sickness and Vertigo
      • Ménière's Disease
      • Travel Sickness
    • Vitamins & Minerals
      • Calcium and Vitamin D Supplementation
  • Our Products
    • Our Products
  • News & Stories
    • News & Stories
    • Choose Sandoz for Biosimilars
    • Corporate Responsibility
    • Listening to Patient Perspectives
    • Ushering in the next wave of Biosimilars by unlocking their potential
  • Sandoz SA PAIA Manual
    • Sandoz SA PAIA Manual
  • Search
Ovarian Cancer - Desktop

Oncology

  1. Home
  2. Therapy Areas
  3. Oncology
  4. Ovarian Cancer

Ovarian Cancer

In 2020 over 300,000 women worldwide were diagnosed with ovarian cancer.1 It most commonly occurs in postmenopausal women and is rare in women under 40 years of age.2

Possible treatment options for ovarian cancer include surgery, chemotherapy, hormone therapy, radiotherapy and supportive care.2

Survival rates continue to improve,3 and a significant number of clinical trials are currently underway assessing newer therapies for patients suffering from ovarian cancer.4

Ovarian Cancer

Cancer patients in South Africa often face high out-of-pocket medical costs.5 These extra costs can prevent or delay access to important medical care.5 Recommendations to remedy this include encouraging the state, the private health sector and other health providers to implement measures to minimize financial challenges.5 

One of the priorities of the National Cancer Strategic Framework for South Africa is to improve access to treatment by reducing financial, geographic, logistical and socio-cultural barriers.5 

Sandoz South Africa has a growing portfolio of generic oncology medications, including products currently listed for the treatment of ovarian cancer on the WHO List of Essential Medicines and in the South African Council for Medical Schemes’ Prescribed Minimum Benefits Guidelines.2,6,7

We are committed to improving both affordability and access to high-quality generic medications for South African cancer patients and healthcare providers.7

References
1.

Globocan 2020. Ovarian Cancer: Global. International Agency for Research on Cancer. Dec 2020

2.

Final PMB Definition Guidelines for Ovarian Cancer. Council for Medical Schemes. 15 Apr 2019

3.

Wu J, Sun H, Yang L, et al. Improved Survival in Ovarian Cancer, with Widening Survival Gaps of Races and Socioeconomic Status: A Period Analysis, 1983-2012. J Cancer. 2018;9(19):3548-3556. doi:10.7150/jca.26300

4.

McMullen M, Karakasis K, Rottapel R, et al. Advances in Ovarian Cancer, from Biology to Treatment. Nat Cancer. 2021;2(1):6-8. doi:10.1038/s43018-020-00166-5

5.

Department of Health, Republic of South Africa. National Cancer Strategic Framework for South Africa 2017 – 2022

6.

WHO Model Lists of Essential Medicines: Adults [Online]. World Health Organization. Cited 31 Aug 2021. Available from: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists

7.

Sandoz SA (Pty) Ltd. Data on File. Sandoz Oncology. Closer to Solutions. 2021

My Sandoz

Navigate My Sandoz
  • Home
  • About Sandoz
  • Therapy Areas
  • Our Products
  • News & Stories
  • Sandoz SA PAIA Manual

ZA2109032375

©2023 Sandoz South Africa

Footer Bottom Links
  • Cookie Settings
  • Terms of Use
  • Website Privacy Policy
  • Business Partner Privacy Policy
  • Site Map
Sandoz Site Directory.

This site is intended for medical professionals within South Africa.